Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4IAJ3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.573 |
CLV_NRD_NRD_1 | 195 | 197 | PF00675 | 0.619 |
CLV_PCSK_FUR_1 | 129 | 133 | PF00082 | 0.670 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.466 |
CLV_PCSK_PC1ET2_1 | 131 | 133 | PF00082 | 0.658 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.537 |
DOC_MAPK_gen_1 | 168 | 176 | PF00069 | 0.484 |
DOC_PP4_FxxP_1 | 162 | 165 | PF00568 | 0.470 |
DOC_USP7_MATH_1 | 92 | 96 | PF00917 | 0.532 |
DOC_USP7_UBL2_3 | 197 | 201 | PF12436 | 0.565 |
DOC_WW_Pin1_4 | 195 | 200 | PF00397 | 0.545 |
LIG_Actin_WH2_2 | 34 | 50 | PF00022 | 0.531 |
LIG_APCC_ABBA_1 | 24 | 29 | PF00400 | 0.411 |
LIG_APCC_ABBAyCdc20_2 | 23 | 29 | PF00400 | 0.390 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.627 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.503 |
LIG_FHA_2 | 44 | 50 | PF00498 | 0.414 |
LIG_Integrin_RGD_1 | 58 | 60 | PF01839 | 0.526 |
LIG_LIR_Gen_1 | 183 | 193 | PF02991 | 0.558 |
LIG_LIR_Nem_3 | 183 | 189 | PF02991 | 0.542 |
LIG_LIR_Nem_3 | 97 | 103 | PF02991 | 0.561 |
LIG_PTB_Apo_2 | 136 | 143 | PF02174 | 0.550 |
LIG_PTB_Phospho_1 | 136 | 142 | PF10480 | 0.551 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.567 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.531 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.531 |
LIG_TRAF2_1 | 180 | 183 | PF00917 | 0.460 |
MOD_CDK_SPK_2 | 195 | 200 | PF00069 | 0.545 |
MOD_CDK_SPxK_1 | 195 | 201 | PF00069 | 0.548 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.470 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.404 |
MOD_Cter_Amidation | 129 | 132 | PF01082 | 0.570 |
MOD_N-GLC_1 | 125 | 130 | PF02516 | 0.678 |
MOD_N-GLC_1 | 92 | 97 | PF02516 | 0.510 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.678 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.526 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.470 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.529 |
MOD_Plk_2-3 | 177 | 183 | PF00069 | 0.470 |
MOD_ProDKin_1 | 195 | 201 | PF00069 | 0.548 |
TRG_DiLeu_BaLyEn_6 | 86 | 91 | PF01217 | 0.552 |
TRG_ENDOCYTIC_2 | 142 | 145 | PF00928 | 0.534 |
TRG_ENDOCYTIC_2 | 186 | 189 | PF00928 | 0.555 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.510 |
TRG_ER_diArg_1 | 113 | 116 | PF00400 | 0.606 |
TRG_ER_diArg_1 | 170 | 173 | PF00400 | 0.481 |
TRG_ER_diArg_1 | 87 | 90 | PF00400 | 0.557 |
TRG_ER_diLys_1 | 200 | 203 | PF00400 | 0.579 |
TRG_NES_CRM1_1 | 16 | 29 | PF08389 | 0.466 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILH1 | Leptomonas seymouri | 93% | 100% |
A0A0S4KPQ6 | Bodo saltans | 61% | 99% |
A0A1X0PA75 | Trypanosomatidae | 74% | 100% |
A0A3S7X8J0 | Leishmania donovani | 100% | 100% |
A4HBE5 | Leishmania braziliensis | 97% | 100% |
C9ZLP7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 75% | 100% |
E9B5L7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |
Q4Q2B9 | Leishmania major | 98% | 100% |
V5BLR3 | Trypanosoma cruzi | 74% | 82% |